IMM 0.79% 31.8¢ immutep limited

wednesday 9 may, page-4

  1. 701 Posts.
    The first Phase 2b interim report will be safety results, not efficacy.
    Safety results will be a yawn fest, we already know it's well tolerated.
    So don't expect any action from that.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.